Page last updated: 2024-09-05

enzastaurin and Experimental Hepatoma

enzastaurin has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bang, YJ; Jang, IJ; Kim, JR; Kim, W; Kim, YJ; Lee, HS; Yoon, JH	1

Other Studies

1 other study(ies) available for enzastaurin and Experimental Hepatoma

Article	Year
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Indoles; Liver Neoplasms, Experimental; Lovastatin; Male; Mice; Mice, Inbred C3H; Microvessels; Neoplasm Transplantation; Protein Kinase C; Protein Kinase C beta	2009

Article

Year

Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.

Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Indoles; Liver Neoplasms, Experimental; Lovastatin; Male; Mice; Mice, Inbred C3H; Microvessels; Neoplasm Transplantation; Protein Kinase C; Protein Kinase C beta

2009